Peisheng Xu
Works at
Sources: reporter.nih.gov
Grants and prizes
Brain-targeted antibody for Alzheimer's disease therapy, R41AG102139, 17 Sept 2026
R41, Develop a novel strategy to deliver N-acetylcysteine for AD treatment, R41AG087769, 2024–2026, 12 Sept 2024
Sources: reporter.nih.gov